In the present study, we for the first time succeeded in establishing a novel CD133+ tumor-initiating cell line in disseminated cancer cells derived from gemcitabine-resistant PDAC patients, using in vitro co-culture system with stromal cell lines. This evidence concerns the gene PROM1 and neoplasm.